Gubra
Virginia Dundas is an accomplished sustainability leader with extensive experience in environmental, social, and governance (ESG) initiatives. Currently serving as Director and Head of ESG at Gubra since May 2025, Virginia previously held several senior roles at Ørsted from June 2018 to December 2024, including Director and Interim Head of Sustainability, where strategic sustainability initiatives were aligned with business value and stakeholder engagement was prioritized. Virginia also contributed to significant sustainability programs at A.P. Moller - Maersk and has expertise in CSR compliance and supply chain decarbonization. With a strong academic background in Business, Language, and Culture from Copenhagen Business School and Business Administration from Universidad Nacional del Litoral, Virginia remains committed to integrating sustainability into corporate strategies and operations.
This person is not in any teams
This person is not in any offices
Gubra
Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.